Condensed Consolidated Statements of Cash Flows (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Apr. 02, 2011
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used for) operating activities	$ (67,509)	$ (48,180)
Investing activities
Capital expenditures	(15,621)	(13,268)
Proceeds from sale of property and equipment	1,528	42
Acquisitions, net of cash acquired		(14,856)
Other	(3,076)	58
Net cash provided by (used for) investing activities	(17,169)	(28,024)
Financing activities
Net short-term borrowings	15,165	1,160
Proceeds from long-term debt	182,976	249,366
Repayment of long-term debt	(94,572)	(150,000)
Excess tax benefits from stock-based compensation	1,384	557
Stock issued to employees, net of shares withheld	7,200	(37)
Repurchases of common stock		(287)
Dividends paid	(22,105)	(19,844)
Net cash provided by (used for) financing activities	90,048	80,915
Effect of exchange rate changes on cash and cash equivalents	(9)	6,367
Change in cash and cash equivalents	5,361	11,078
Cash and cash equivalents, beginning of period	50,077	46,056
Cash and cash equivalents, end of period	55,438	57,134
Parent Company
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used for) operating activities	(8,291)	(32,301)
Investing activities
Capital expenditures	(1,059)	(1,129)
Other		234
Net cash provided by (used for) investing activities	(1,059)	(895)
Financing activities
Net short-term borrowings	15,165	1,160
Proceeds from long-term debt	182,976	249,366
Repayment of long-term debt	(94,572)	(150,000)
Net change in advances to subsidiaries	(81,959)	(15,920)
Excess tax benefits from stock-based compensation	1,384	557
Stock issued to employees, net of shares withheld	7,200	(37)
Repurchases of common stock		(287)
Dividends paid	(22,105)	(19,835)
Net cash provided by (used for) financing activities	8,089	65,004
Effect of exchange rate changes on cash and cash equivalents	1,894	(30,324)
Change in cash and cash equivalents	633	1,484
Cash and cash equivalents, beginning of period	3,097	3,201
Cash and cash equivalents, end of period	3,730	4,685
Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used for) operating activities	(79,455)	17,385
Investing activities
Capital expenditures	(8,090)	(6,112)
Proceeds from sale of property and equipment	(10)	23
Other		(176)
Net cash provided by (used for) investing activities	(8,100)	(6,265)
Financing activities
Net short-term borrowings		(33)
Net change in advances to subsidiaries	95,080	(104,670)
Net cash provided by (used for) financing activities	95,080	(104,703)
Effect of exchange rate changes on cash and cash equivalents		93,181
Change in cash and cash equivalents	7,525	(402)
Cash and cash equivalents, beginning of period	3,332	3,404
Cash and cash equivalents, end of period	10,857	3,002
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used for) operating activities	20,237	(33,264)
Investing activities
Capital expenditures	(6,472)	(6,027)
Proceeds from sale of property and equipment	1,538	19
Acquisitions, net of cash acquired		(14,856)
Other	(3,076)
Net cash provided by (used for) investing activities	(8,010)	(20,864)
Financing activities
Net short-term borrowings		33
Net change in advances to subsidiaries	(13,121)	120,590
Dividends paid		(9)
Net cash provided by (used for) financing activities	(13,121)	120,614
Effect of exchange rate changes on cash and cash equivalents	(1,903)	(56,490)
Change in cash and cash equivalents	(2,797)	9,996
Cash and cash equivalents, beginning of period	43,648	39,451
Cash and cash equivalents, end of period	$ 40,851	$ 49,447